Related Experiment Video
Updated: Jun 2, 2026

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
Published on: April 17, 2017
Hepatitis C virus hijacks P-body and stress granule components around lipid droplets
Yasuo Ariumi1, Misao Kuroki, Yukihiro Kushima
1Center for AIDS Research, Kumamoto University, 2-2-1 Honjo, Kumamoto 860-0811, Japan. ariumi@kumamoto-u.ac.jp
Abstract:
The microRNA miR-122 and DDX6/Rck/p54, a microRNA effector, have been implicated in hepatitis C virus (HCV) replication. In this study, we demonstrated for the first time that HCV-JFH1 infection disrupted processing (P)-body formation of the microRNA effectors DDX6, Lsm1, Xrn1, PATL1, and Ago2, but not the decapping enzyme DCP2, and dynamically redistributed these microRNA effectors to the HCV production factory around lipid droplets in HuH-7-derived RSc cells. Notably, HCV-JFH1 infection also redistributed the stress granule components GTPase-activating protein (SH3 domain)-binding protein 1 (G3BP1), ataxin-2 (ATX2), and poly(A)-binding protein 1 (PABP1) to the HCV production factory. In this regard, we found that the P-body formation of DDX6 began to be disrupted at 36 h postinfection. Consistently, G3BP1 transiently formed stress granules at 36 h postinfection. We then observed the ringlike formation of DDX6 or G3BP1 and colocalization with HCV core after 48 h postinfection, suggesting that the disruption of P-body formation and the hijacking of P-body and stress granule components occur at a late step of HCV infection. Furthermore, HCV infection could suppress stress granule formation in response to heat shock or treatment with arsenite. Importantly, we demonstrate that the accumulation of HCV RNA was significantly suppressed in DDX6, Lsm1, ATX2, and PABP1 knockdown cells after the inoculation of HCV-JFH1, suggesting that the P-body and the stress granule components are required for the HCV life cycle. Altogether, HCV seems to hijack the P-body and the stress granule components for HCV replication.
Insights
Hepatitis C virus (HCV) infection disrupts cellular P-bodies and stress granules, hijacking their components for viral replication. Knockdown of these components significantly reduces HCV RNA accumulation, highlighting their essential role in the viral life cycle.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- MicroRNA (miRNA) pathways, including the roles of miR-122 and miRNA effectors like DDX6, are crucial for Hepatitis C Virus (HCV) replication.
- P-bodies and stress granules are cellular structures involved in mRNA regulation and stress response.
Purpose of the Study:
- To investigate the impact of HCV-JFH1 infection on P-body and stress granule formation and dynamics.
- To determine if these cellular components are essential for HCV replication.
Main Methods:
- Utilized HuH-7-derived RSc cells for HCV-JFH1 infection studies.
- Observed the dynamic redistribution of miRNA effectors (DDX6, Lsm1, Xrn1, PATL1, Ago2) and stress granule components (G3BP1, ATX2, PABP1) using microscopy.
- Performed knockdown experiments for DDX6, Lsm1, ATX2, and PABP1 to assess their role in HCV RNA accumulation.
- Investigated the effect of HCV infection on stress granule formation under induced stress conditions (heat shock, arsenite).
Main Results:
- HCV-JFH1 infection disrupted P-body formation and redistributed miRNA effectors and stress granule components to sites of viral production around lipid droplets.
- Disruption of P-body formation and redistribution of components occurred at late stages of infection (≥36-48 hours post-infection).
- HCV infection suppressed stress granule formation in response to cellular stress.
- Knockdown of DDX6, Lsm1, ATX2, and PABP1 significantly reduced HCV RNA accumulation, indicating their necessity for viral replication.
Conclusions:
- HCV hijacks P-body and stress granule components, essential for its replication.
- Disruption of P-bodies and recruitment of their components to viral factories are key events in the late stage of HCV infection.
- Targeting these cellular components could represent a novel therapeutic strategy against HCV.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Viruses with RNA Genomes
Regulation of Nuclear Protein Sorting
Cirrhosis II: Pathophysiology

